Pradaxa is an anticoagulant medicine (a medicine that prevents blood clotting) used for: * preventing the formation of blood clots in the veins of adults who have had an operation to replace a hip or knee; * preventing stroke (caused by a blood clot in the brain) and systemic embolism (a blood clot in another organ) in adults who have an abnormal heartbeat called;non\-valvular atrial fibrillation; and are considered to be at risk of stroke; * treating deep vein thrombosis (DVT, a blood clot in a deep vein, usually in the leg) and pulmonary embolism (PE, a clot in a blood vessel supplying the lungs) in adults, and preventing these conditions from occurring again; * treating blood clots in veins and preventing them from occurring again in children. Pradaxa contains the active substance dabigatran etexilate.
Therapeutic Indication
Pradaxa 75 mg * Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery. Pradaxa 110 mg * Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery. * Prevention of stroke and systemic embolism in adult patients with non\-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischemic attack (TIA); age ≥ 75 years; heart failure (NYHA Class ≥ II); diabetes mellitus; hypertension. * Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults. Pradaxa 150 mg * Prevention of stroke and systemic embolism in adult patients with non\-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischemic attack (TIA); age ≥ 75 years; heart failure (NYHA Class ≥ II); diabetes mellitus; hypertension. * Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
Therapeutic Area (MeSH)
ATC Code
B01AE07
ATC Item
N/A
Pharmacotherapeutic Group
Antithrombotic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| dabigatran etexilate mesilate | N/A | dabigatran etexilate mesilate |
EMA Name
Pradaxa
Medicine Name
Pradaxa
Aliases
N/ANo risk management plan link.
